切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2023, Vol. 09 ›› Issue (03) : 274 -279. doi: 10.3877/cma.j.issn.2096-1537.2023.03.007

综述

CRRT超滤应用现状及其对危重症患者预后影响的研究进展
赵宸龙, 林瑾, 冀晓俊, 段美丽()   
  1. 100050 北京,首都医科大学附属北京友谊医院重症医学科
  • 收稿日期:2021-10-28 出版日期:2023-08-28
  • 通信作者: 段美丽
  • 基金资助:
    北京市属医院科研培育计划项目(PX2021003)

Current applications of ultrafiltration and its impact on prognosis of critically ill patients undergoing continuous renal replacement therapy

Chenlong Zhao, Jin Lin, Xiaojun Ji, Meili Duan()   

  1. Department of Critical Care Medicine, Beijing Friendship Hospital, Captical Medical University, Beijing 100050, China
  • Received:2021-10-28 Published:2023-08-28
  • Corresponding author: Meili Duan
引用本文:

赵宸龙, 林瑾, 冀晓俊, 段美丽. CRRT超滤应用现状及其对危重症患者预后影响的研究进展[J]. 中华重症医学电子杂志, 2023, 09(03): 274-279.

Chenlong Zhao, Jin Lin, Xiaojun Ji, Meili Duan. Current applications of ultrafiltration and its impact on prognosis of critically ill patients undergoing continuous renal replacement therapy[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(03): 274-279.

液体管理是危重症患者管理的重要环节之一,液体过负荷状态对危重症患者的预后产生不良影响。目前超滤已广泛用于危重症患者的液体清除治疗,研究表明净超滤率与危重症患者预后相关,然而可以改善预后的最佳净超滤率仍未达成共识。本文将连续性肾脏替代治疗(CRRT)超滤应用现状及其对危重症患者预后的影响作一综述,为重症医师明确超滤概念,应用超滤进行容量管理提供参考,以更充分发挥CRRT治疗效果,防止超滤设定不合理对患者产生不良影响。

Fluid management is one of the key components of the management of critically ill patients. Fluid overload in critically ill patients has a strong adverse impact on prognosis. Nowadays, ultrafiltration has been used for fluid removal in critically ill patients. Studies have shown that the net ultrafiltration rate is related to the prognosis of critically ill patients, however, there is still no consensus on the best net ultrafiltration rate. This article focuses on the concept and mechanism of ultrafiltration, the application of ultrafiltration for volume management, the relationship between net ultrafiltration rate and prognosis, and the application of ultrafiltration in different diseases.

表1 接受RRT的危重症患者的净超滤率与不良预后之间的相互关系
1
Levy MM, Artigas A, Phillips GS, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study [J]. Lancet Infect Dis, 2012, 12(12): 919-924.
2
Claure-Del GR, Mehta RL. Fluid overload in the ICU: evaluation and management [J]. BMC Nephrol, 2016, 17(1): 109.
3
Van BW, Yegenaga I, Vanholder R, et al. Relationship between fluid status and its management on acute renal failure in intensive care unit patients with sepsis: a prospective analysis [J]. J Nephrol, 2005, 18(1): 54-60.
4
Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury [J]. Kidney Int, 2009, 76(4): 422-427.
5
Boyd JH, Forbes J, Nakada TA, et al. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality [J]. Crit Care Med, 2011, 39(2): 259-265.
6
Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update2017: expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine [J]. Intensive Care Med, 2017, 43 (6): 730-749.
7
Murugan R, Ostermann M, Peng Z, et al. Net ultrafiltration prescription and practice among critically ill patients receiving renal replacement therapy: a multinational survey of critical care practitioners [J]. Crit Care Med, 2020, 48(2): e87-97.
8
Alwall N. On the artificial kidney; apparatus for dialysis of the blood in vivo [J]. Acta Med Scand, 1947, 128(4): 317-325.
9
Ronco C, Ghezzi PM, Brendolan A, et al. The haemodialysis system: basic mechanisms of water and solute transport in extracorporeal renal replacement therapies [J]. Nephrol Dial Transplant, 1998, 13(Suppl 6): 3-9.
10
Neri M, Villa G, Garzotto F, et al. Nomenclature for renal replacement therapy in acute kidney injury: basic principles [J]. Crit Care, 2016, 20(1): 318.
11
Ronco C, Ricci Z, Bellomo R, et al. Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure [J]. Cardiology, 2001, 96(3-4): 155-68.
12
Ronco C, 张凌, 陆任华, 等. 重症肾脏替代治疗和血液净化技术的标准化术语命名 [J]. 华西医学, 2018, 33(7): 782-796.
13
Ronco C, Brendolan A, Feriani M, et al. A new scintigraphic method to characterize ultrafiltration in hollow fiber dialyzers [J]. Kidney Int, 1992, 41(5): 1383-1393.
14
Bellomo R, Cass A, Cole L, et al. An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial [J]. Crit Care Med, 2012, 40(6): 1753-1760.
15
Murugan R, Hoste E, Mehta RL, et al. Precision fluid management in continuous renal replacement therapy [J]. Blood Purif, 2016, 42(3): 266-278.
16
Balakumar V, Murugan R. Kidney replacement therapy for fluid management [J]. Crit Care Clin, 2021, 37(2): 433-452.
17
Balakumar V, Murugan R, Sileanu FE, et al. Both positive and negative fluid balance may be associated with reduced long-term survival in the critically ill [J]. Crit Care Med, 2017, 45(8): e749-757.
18
Murugan R, Bellomo R, Palevsky PM, et al. Ultrafiltration in critically ill patients treated with kidney replacement therapy [J]. Nat Rev Nephrol, 2021, 17(4): 262-276.
19
Flythe JE, Curhan GC, Brunelli SM. Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain [J]. Clin J Am Soc Nephrol, 2013, 8(7): 1151-1161.
20
Burton JO, Jefferies HJ, Selby NM, et al. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function [J]. Clin J Am Soc Nephrol, 2009, 4(12): 1925-1931.
21
Murugan R, Balakumar V , Kerti SJ, et al. Net ultrafiltration intensity and mortality in critically ill patients with fluid overload [J]. Crit Care, 2018, 22(1): 223.
22
Tehranian S, Shawwa K, Kashani KB. Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy [J]. Clin Kidney J, 2019, 14(2): 564-569.
23
Murugan R, Kerti SJ, Chang CH, et al. Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial [J]. JAMA Netw Open, 2019, 2(6): e195418.
24
Naorungroj T, Neto AS, Zwakman-Hessels L, et al. Early net ultrafiltration rate and mortality in critically ill patients receiving continuous renal replacement therapy [J]. Nephrol Dial Transplant, 2021, 36(6): 1112-1119.
25
Naorungroj T, Neto AS, Zwakman-Hessels L, et al. Mediators of the impact of hourly net ultrafiltration rate on mortality in critically ill patients receiving continuous renal replacement therapy [J]. Crit Care Med, 2020, 48(10) : e934-e942.
26
Flythe JE, Kimmel SE, Brunelli SM, et al. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality [J]. Kidney Int, 2011, 79(2): 250-257.
27
Kim TW, Chang TI, Kim TH, et al. Association of ultrafiltration rate with mortality in incident hemodialysis patients [J]. Nephron, 2018, 139(1): 13-22.
28
Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS [J]. Kidney Int, 2006, 69(7): 1222-1228.
29
Assimon MM, Wenger JB, Wang L, et al. Ultrafiltration rate and mortality in maintenance hemodialysis patients [J]. Am J Kidney Dis, 2016, 68(6): 911-922.
30
Serpa NA, Naorungroj T, Murugan R, et al. Heterogeneity of effect of net ultrafiltration rate among critically ill adults receiving continuous renal replacement therapy [J]. Blood Purif, 2021, 50(3): 336-346.
31
Ross JS, Chen J, Lin Z, et al. Recent national trends in readmission rates after heart failure hospitalization [J]. Circ Heart Fail, 2010, 3(1): 97-103.
32
Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure [J]. J Am Coll Cardiol, 2007, 49(6): 675-83.
33
Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome [J]. N Engl J Med, 2012, 367(24): 2296-2304.
34
Costanzo MR, Negoianu D, Jaski BE, et al. Aquapheresis versus intravenous diuretics and hospitalizations for heart failure [J]. JACC Heart Fail, 2016, 4(2): 95-105.
35
Marenzi G, Muratori M, Cosentino ER, et al. Continuous ultrafiltration for congestive heart failure: the CUORE Trial [J]. J Card Fail, 2014, 20(1): 9-17.
36
Wobbe B, Wagner J, Szabó DK, et al. Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis [J]. Heart Fail Rev, 2021, 26(3): 577-585.
37
Mao H, Katz N, Ariyanon W, et al. Cardiac surgery-associated acute kidney injury [J]. Blood Purif, 2014, 37(suppl 2): 34-50.
38
Vandenberghe W, Gevaert S, Kellum JA, et al. Acute kidney injury in cardiorenal syndrome type 1 patients: a systematic review and meta-analysis [J]. Cardiorenal Med, 2016, 6(2): 116-128.
39
Machado MN, Nakazone MA, Maia LN. Prognostic value of acute kidney injury after cardiac surgery according to Kidney Disease: Improving Global Outcomes definition and staging (KDIGO) criteria [J]. PLoS One, 2014, 9(5): e98028.
40
Koc V, Delmas BL, de With E, et al. The effect of fluid overload on attributable morbidity after cardiac surgery: a retrospective study [J]. Crit Care Res Pract, 2020, 2020: 4836862.
41
Wu B, Sun J, Liu S, et al. Relationship among mortality of patients with acute kidney injury after cardiac surgery, fluid balance and ultrafiltration of renal replacement therapy: an observational study [J]. Blood Purif, 2017, 44(1): 32-39.
42
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 [J]. Intensive Care Med, 2017, 43(3): 304-377.
43
Acheampong A, Vincent JL. A positive fluid balance is an independent prognostic factor in patients with sepsis [J]. Crit Care, 2015, 19(1): 251.
44
de Oliveira FS, Freitas FG, Ferreira EM, et al. Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock [J]. J Crit Care, 2015, 30(1): 97-101.
45
孙治平, 孙伏喜, 牛常明, 等. 连续性肾脏替代治疗及其液体负平衡可改善脓毒性急性肾损伤患者的肾功能和预后 [J]. 中华危重病急救医学, 2015, 27(5): 321-326.
46
Jhee JH, Lee HA, Kim S, et al. The interactive effects of input and output on managing fluid balance in patients with acute kidney injury requiring continuous renal replacement therapy [J]. Crit Care, 2019, 23(1): 329.
47
Ospina-Tascón GA, Hernandez G, Alvarez I, et al. Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis [J]. Crit Care, 2020, 24(1): 52.
[1] 韩媛媛, 热孜亚·萨贝提, 冒智捷, 穆福娜依·艾尔肯, 陆晨, 桑晓红, 阿尔曼·木拉提, 张丽. 组合式血液净化治疗对脓毒症患者血清炎症因子水平和临床预后的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 272-278.
[2] 王育凯, 陈军贤, 施小伟, 吴本权. 连续性肾脏替代治疗联合乌司他丁对严重脓毒症患者临床疗效的Meta分析[J]. 中华危重症医学杂志(电子版), 2021, 14(04): 297-307.
[3] 夏荣霞, 祝成红, 郑燕芳, 涂晓文. 尿毒症患者糖尿病足截肢术围手术期血液净化治疗方案的选择及护理[J]. 中华损伤与修复杂志(电子版), 2021, 16(01): 68-70.
[4] 王增鲜, 王婧, 杨淑怡. 目标导向液体管理策略在腹腔镜肝切除术中对患者组织灌注及应激反应的影响[J]. 中华普通外科学文献(电子版), 2023, 17(02): 134-138.
[5] 徐艳, 何重香, 周鑫, 潘丽, 叶啟发. 肾移植术后液体管理改善移植肾功能延迟恢复的研究进展[J]. 中华移植杂志(电子版), 2021, 15(06): 370-374.
[6] 陈杰桓, 许志荣, 刘颖培, 杨帅, 周芙蓉, 陈斌, 谭雷. 超声造影对急性肾损伤治疗后肾血流灌注水平的评价[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 58-62.
[7] 许磊, 孙杰, 陈先志, 张家泉, 李旺勇, 冯其柱, 王琦. 血液净化治疗在高血脂性重症胰腺炎中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 464-468.
[8] 于天宇, 杨悦, 陆海涛, 田志永, 李文歌. 高龄急性肾损伤患者连续性肾脏替代治疗的预后及影响因素[J]. 中华肾病研究电子杂志, 2023, 12(03): 134-138.
[9] 朱利娟, 张卉卉, 纪明慧, 邓芳. 局部枸橼酸抗凝在危重症患儿连续性肾脏替代治疗中的应用进展[J]. 中华肾病研究电子杂志, 2021, 10(05): 274-277.
[10] 冯哲. CRRT治疗重症急性胰腺炎:时机与方案[J]. 中华肾病研究电子杂志, 2021, 10(03): 180-180.
[11] 刘珊, 邬步云, 刘康, 俞香宝, 朱亚梅, 邵永丰, 赵胜, 邢昌赢, 毛慧娟. 心血管手术相关急性肾损伤患者行连续性肾脏替代治疗后的预后因素分析[J]. 中华肾病研究电子杂志, 2020, 09(04): 159-165.
[12] 高学慧, 邹晓静, 杨小博, 尚游. 甲磺酸萘莫司他在重症患者CRRT与ECMO中抗凝应用的研究进展[J]. 中华重症医学电子杂志, 2023, 09(02): 210-216.
[13] 刘娇, 王敏敏, 刘永安, 杜航向, 汪涛, 张李迪, 陈一竹, 陈彦, 陈德昌. 连续性肾脏替代治疗处方实践与脓毒症血液净化[J]. 中华重症医学电子杂志, 2020, 06(03): 260-266.
[14] 周楚瑶, 孙融. 枸橼酸局部抗凝在肝功能不全患者连续性肾脏替代治疗中的安全性评价[J]. 中华重症医学电子杂志, 2020, 06(01): 86-91.
[15] 刘振良, 廖宪友, 周杨杰, 李万能, 周德丽. 急性心力衰竭伴容量超负荷住院患者早期应用超滤治疗的有效性和安全性[J]. 中华临床医师杂志(电子版), 2021, 15(07): 526-531.
阅读次数
全文


摘要